Navigation Links
Christopher and Dana Reeve Paralysis Act Signed by President Obama as Part of Omnibus Public Land Bill
Date:3/30/2009

Christopher & Dana Reeve Foundation expresses appreciation to Congressional co-sponsors for passing first legislation specific to the paralysis community

SHORT HILLS, N.J., March 30 /PRNewswire-USNewswire/ -- The Christopher & Dana Reeve Foundation, the national, non-profit organization dedicated to finding cures and treatments for spinal cord injuries and improving the lives of people living with paralysis, applauds President Obama for signing the Omnibus Public Lands Bill. Passed by the U.S. House of Representatives on March 25 and the U.S. Senate on January 15, Title XIV of the Bill contains the Christopher and Dana Reeve Paralysis Act. The Act was named for the late Christopher Reeve and his wife Dana, whose courage and grace in the face of adversity, coupled with their extraordinary activism, were an inspiration to millions around the world.

The landmark legislation, which enjoyed bi-partisan support, will promote collaborative research, rehabilitation and quality of life initiatives for millions of Americans living with paralysis and spinal cord injuries. It was introduced in the Senate by Tom Harkin (D-IA), who worked closely together with Christopher and Dana Reeve to promote expanded research and quality of life for people living with paralysis, particularly spinal cord injuries.

Peter T. Wilderotter, president and CEO of the Reeve Foundation, remarked, "In less than one month, with swift action, President Obama has twice expedited the promise of hope of medical research for so many. We commend his continuing commitment to improving the lives of millions living with paralysis."

Wilderotter continued, "The Christopher & Dana Reeve Paralysis Act will expedite the search for cures and treatments for millions of Americans living with paralysis caused by spinal cord injury, stroke, MS, Parkinson's and many other diseases and disorders. On behalf of the Reeve Foundation, I would like to express our appreciation of Senator Harkin, who for so many years has devoted his career to others. Senator Harkin has been a wonderful friend to the Reeve family and the Reeve Foundation. People living with paralysis all over this country are celebrating today because of his dedication and commitment to the disability community."

Wilderotter added, "In addition to Senator Harkin's efforts, we thank Senators Thad Cochran (R-MS) and Edward Kennedy (D-MA) for initially sponsoring this important health bill. Also, I would like to express our appreciation to Chairman Jeff Bingaman (D-NM) for including the Reeve Act in the Omnibus Public Land Management Act and for his support of the paralysis community. In addition, we express our appreciation to Majority Leader Harry Reid (D-NV) and Majority Whip Dick Durbin (D-IL) for their resolve to bring this bill before the Senate.

"On January 8, 2009, Congresswomen Tammy Baldwin (D-WI) introduced this Act in the House, along with her colleagues Congressmen Mary Bono Mack (R-CA), Jim Langevin (D-RI) and Gus Bilirakis (R-FL). Their extraordinary leadership and tireless efforts were instrumental in passing this historic legislation."

Wilderotter concluded, "Advancements are made every day in spinal cord injury research, but the Christopher and Dana Reeve Paralysis Act will speed progress and make research efforts more efficient."

The Act has three components that support and enhance paralysis research, rehabilitation, and quality of life programs:

  • Paralysis Research - Expands research on paralysis at the National Institutes of Health (NIH). This will encourage collaborative research by connecting scientists conducting similar work to further enhance understanding and speed discovery of better treatments and cures.
  • Paralysis Rehabilitation and Care - Builds on research to enhance daily function for people with paralysis, including a Clinical Trials Network, to measure effectiveness of certain rehabilitation tactics and encouraging shared findings on paralysis to improve rehabilitation.
  • Improving Quality of Life for Persons with Paralysis and Other Physical Disabilities - Works with the Centers for Disease Control and Prevention (CDC) to improve the quality of life and long-term health status of persons with paralysis and other physical disabilities.

About the Christopher & Dana Reeve Foundation

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy. For more information, please visit our website at www.ChristopherReeve.org or call 800-225-0292.


'/>"/>
SOURCE The Christopher and Dana Reeve Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Christopher & Dana Reeve Foundation Applauds Historic Passage of the Christopher and Dana Reeve Paralysis Act
2. Christopher & Dana Reeve Foundation Commends President Obamas Decision to Lift Federal Restrictions on Stem Cell Research
3. Dave Annable Named Christopher & Dana Reeve Foundation Ambassador
4. St. Christophers Hospital for Children Earns National Recognition for Nursing Excellence
5. Christopher & Dana Reeve Foundation Applauds Senate Passage of the Christopher and Dana Reeve Paralysis Act
6. AdvancedMD Software Names Tech Veteran, Christopher J. Bijou, as Executive Vice President of Sales : Executive to Drive Growth of Software as a Service for Medical Practice Management Industry
7. AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of Sleep Better America Campaign
8. Christopher & Dana Reeve Foundation Launches First-Ever National Advertising Campaign
9. Chicago Artist Tadeusz Seidel Supports Christopher & Dana Reeve Foundation Chicago Chapter Benefit
10. Matthew Reeve to Host The Christopher and Dana Reeve Foundations Annual Hamptons Summer Soiree
11. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... A new ... with severe congenital diaphragmatic hernia have better survival rates if surgery is performed ... (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs into ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... won the $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan ... the Michelson People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... 2016 Im ... Zürich gab Strekin AG den Start einer ... Erhaltung des Resthörvermögens von Patienten, denen ein ... umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan Patienten ... während der Operation direkt ins Mittelohr verabreicht. ...
(Date:4/27/2016)... , April 27, 2016 ... Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor ... announced its sales for the first quarter ended March ... and the execution of its commercial strategy. ...
Breaking Medicine Technology: